Clinical Trial Update: MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study [Phase 3]

View source ↗

Summary

The Phase 3 study evaluating cannabis extract (MUSEC) for muscle spasticity in multiple sclerosis was terminated. No efficacy results are provided in this updat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MUSEC cannabis extract (cannabis extract)

Snippet

Sponsor: Institut fur Klinische Forschung, Germany | Conditions: Muscle Spasticity | Phase 3 | Status: TERMINATED